Maria Vazquez-Roque, MD
Gastroenterology · Jacksonville, FLNPI 1841408804
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $11,613 of the $14,450 with a category attached, or 80.4%. Ferring Pharmaceuticals Inc. accounts for 90.0% of it on its own, with 2 other manufacturers making up the rest.
Across 19 payments — averaging $760.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ferring Pharmaceuticals Inc.$13K
- Boston Scientific$1K
- Merck$31
Across 1 payment — averaging $30,426 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Rebiotix Inc.$30K
What the payments were for
- Consulting fees$11,61380%
- Travel & lodging$2,23215%
- Food & beverage$6064%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ferring Pharmaceuticals Inc. | 12 | $13,007 |
| Boston Scientific | 6 | $1,412 |
| Merck | 1 | $31 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- REBYOTA$9,015
- EXALT Model D$1,377
How this compares
$14,450 in reported general payments places this provider in the 85th percentile of 1,388 gastroenterology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Vancomycin Hcl | 13 | $1,066 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Jacksonville
- Francis FarrayeJacksonville$395K
- Jami KinnucanJacksonville$313K
- Vivek KumbhariJacksonville$254K
- Ali Moghani LankaraniJacksonville$105K
- Ana CorregidorJacksonville$79K
- Mark FleisherJacksonville$74K
- Victoria GomezJacksonville$65K
- Samuel GidayOrlando$2M
- Lukasz KwapiszMiami$1.2M
- Jennifer Seminerio-DiehlOrlando$1.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.